Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children

PHASE3CompletedINTERVENTIONAL
Enrollment

347

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

August 31, 2019

Conditions
Chronic Lung DiseaseHIV Infection
Interventions
DRUG

Azithromycin

DRUG

Placebo

Trial Locations (2)

30096

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre

Unknown

Biomedical Research and Training Institute, Harare

All Listed Sponsors
collaborator

Biomedical Research and Training Institute, Zimbabwe

OTHER

collaborator

Malawi-Liverpool-Wellcome Trust Clinical Research Programme

OTHER

collaborator

University of Tromso

OTHER

collaborator

University of Cape Town

OTHER

collaborator

University of Oxford

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT02426112 - Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children | Biotech Hunter | Biotech Hunter